5 :: KDA, Korean Diabetes Association ::
Subject    :    Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
Writer KDA
Date 2020-03-17 10:07:36 Hit 1,275
LINK URL https://e-dmj.org/search.php?where=aview&id=10.4093/dmj.2017.41.5.367&code=2004DMJ&vmode=FULL (Click 133)
Review  Open Access

         

   
Diabetes Metab J. 2017 Oct;41(5):367-373. English.
Published online Oct 24, 2017.  https://doi.org/10.4093/dmj.2017.41.5.367
Copyright © 2017 Korean Diabetes Association
   
Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
Byung-Wan Lee,1,* Jin Hwa Kim,2,* Seung-Hyun Ko,3 Kyu-Yeon Hur,4 Nan-Hee Kim,5 Sang Youl Rhee,6 Hyun Jin Kim,7 Min Kyong Moon,8 Seok-O Park,9 Kyung Mook Choi,5 and Committee of Clinical Practice Guideline of Korean Diabetes Association
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
2Division of Endocrinology and Metabolism, Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea.
3Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
4Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
5Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
6Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.
7Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.
8Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
9Department of Internal Medicine, Gwangmyeong Sungae Hospital, Gwangmyeong, Korea.

Corresponding author: Seung-Hyun Ko. Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent' Hospital, College of Medicine, The Catholic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Korea. Email: kosh@catholic.ac.kr

 

*Byung-Wan Lee and Jin Hwa Kim contributed equally to this study as first authors.
 
Received September 08, 2017; Accepted September 25, 2017.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.



Abstract

The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

   
Keywords:
Clinical practice guideline; Diabetes mellitus, type 2; Hypoglycemic agents; Insulin; Korea

No. Subject Name Date Hit ↓
Notice : 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Ko... jiyeon 2020-03-17 1,930
Notice : Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type ... jiyeon 2020-03-17 1,348
Notice : Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017 Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A ... jiyeon 2020-03-17 1,275
Notice : Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus Combination Therapy of Oral Hypoglycemic Agents in Patients with Typ... jiyeon 2020-03-17 1,189
Notice : Monotherapy in Patients with Type 2 Diabetes Mellitus Monotherapy in Patients with Type 2 Diabetes Mellitus jiyeon 2020-03-17 943
Notice : Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabe... jiyeon 2020-03-17 882
2 2015 Treatment Guidelines for Diabetes (5th edition) jiyeon 2020-12-03 808
1 2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea jiyeon 2020-03-17 932

목록

Gets the previous 5 pages.   Go to previous page.  [1]     Go to next page.  Gets the next  5 pages.